BTI-322 for acute rejection after renal transplantation.
Mourad
M
M
Department of Renal and Pancreatic Transplantation, University of Louvain Medical School, Cliniques St-Luc, Brussels, Belgium.
Besse
T
T
Malaise
J
J
Baldi
A
A
Latinne
D
D
Bazin
H
H
Pirson
Y
Y
Hope
J
J
Squifflet
J P
JP
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018801:CD2 Antigens / Q000276:immunology; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D016030:Kidney Transplantation; D051381:Rats; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D018801:CD2 Antigens; C105249:LO-CD2a